These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9701277)

  • 1. Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients.
    Minghelli G; Seydoux C; Goy JJ; Burnier M
    Transplantation; 1998 Jul; 66(2):268-71. PubMed ID: 9701277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
    Schmidt A; Gruber U; Böhmig G; Köller E; Mayer G
    Nephrol Dial Transplant; 2001 May; 16(5):1034-7. PubMed ID: 11328912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the angiotensin II receptor antagonist losartan on uric acid and oxypurine metabolism in healthy subjects.
    Hamada T; Hisatome I; Kinugasa Y; Matsubara K; Shimizu H; Tanaka H; Furuse M; Sonoyama K; Yamamoto Y; Ohtahara A; Igawa O; Shigemasa C; Yamamoto T
    Intern Med; 2002 Oct; 41(10):793-7. PubMed ID: 12412998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
    Würzner G; Gerster JC; Chiolero A; Maillard M; Fallab-Stubi CL; Brunner HR; Burnier M
    J Hypertens; 2001 Oct; 19(10):1855-60. PubMed ID: 11593107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uricosuric effect of losartan in patients with renal transplants.
    Kamper AL; Nielsen AH
    Transplantation; 2001 Aug; 72(4):671-4. PubMed ID: 11544429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To study the efficacy of Losartan on urinary uric acid excretion in Thiazide induced hyperuricemic and hypertensive patients.
    Khan M; Khan RA; Islam F; Laghari J; Jamali SN
    Pak J Pharm Sci; 2011 Oct; 24(4):583-7. PubMed ID: 21959825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension.
    Puig JG; Mateos F; Buño A; Ortega R; Rodriguez F; Dal-Ré R
    J Hypertens; 1999 Jul; 17(7):1033-9. PubMed ID: 10419078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
    Mazzali M; Kanellis J; Han L; Feng L; Xia YY; Chen Q; Kang DH; Gordon KL; Watanabe S; Nakagawa T; Lan HY; Johnson RJ
    Am J Physiol Renal Physiol; 2002 Jun; 282(6):F991-7. PubMed ID: 11997315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.
    Yee KM; Struthers AD
    Br J Clin Pharmacol; 1998 Dec; 46(6):583-8. PubMed ID: 9862248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome.
    Masajtis-Zagajewska A; Majer J; Nowicki M
    J Renin Angiotensin Aldosterone Syst; 2021; 2021():2214978. PubMed ID: 34527078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AT1 blockers and uric acid metabolism: are there relevant differences?
    Puig JG; Torres R; Ruilope LM
    J Hypertens Suppl; 2002 Jun; 20(5):S29-31. PubMed ID: 12184060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
    Goodfield NE; Newby DE; Ludlam CA; Flapan AD
    Circulation; 1999 Jun; 99(23):2983-5. PubMed ID: 10368114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia.
    Shahinfar S; Simpson RL; Carides AD; Thiyagarajan B; Nakagawa Y; Umans JG; Parks JH; Coe FL
    Kidney Int; 1999 Nov; 56(5):1879-85. PubMed ID: 10571797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
    Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
    J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension.
    Smith MC; Barrows S; Meibohm A; Shahinfar S; Simpson RL; Weigel K; Dunn MJ
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1177-83. PubMed ID: 8998251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial.
    Li-Saw-Hee FL; Beevers DG; Lip GY
    Int J Cardiol; 2001 May; 78(3):241-6. PubMed ID: 11376827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
    J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.
    Davie AP; Dargie HJ; McMurray JJ
    Circulation; 1999 Jul; 100(3):268-73. PubMed ID: 10411851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.